Breaking News, Promotions & Moves

BioAgilytix Names Two New Scientific Officers

Lynn Kamen and Michelle Miller offer over two decades of experience combined in drug discovery, development and immunology and toxicology.

Author Image

By: Charlie Sternberg

Associate Editor

BioAgilytix Labs LLC, a global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, has appointed two new scientific officers.   Lynn Kamen and Michelle Miller bring with them more than two decades of experience combined in drug discovery, development and immunology and toxicology.   The addition of Kamen and Miller to the Scientific Office brings the total number on that team to five.   Jim McNally, chief scientific of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters